Sosum PCL
-
Livraison estimée :Feb 15 - Feb 19
-
Livraison et retours gratuits : sur toutes les commandes de plus de 999,9 $
SOSUM PCL Solution is a cutting-edge collagen regenerative cosmetic designed for advanced facial tissue augmentation. The primary ingredient in this innovative solution is Polycaprolactone (PCL), a biodegradable polymer known for its exceptional regenerative properties. SOSUM PCL Solution is specifically formulated to correct soft tissue defects, making it an ideal choice for enhancing facial contours and improving skin texture.
Key Benefits:
- Collagen Regeneration: Promotes the natural regeneration of collagen, essential for youthful and firm skin.
- Soft Tissue Augmentation: Effectively addresses defects in soft tissue, offering a non-surgical option for facial enhancement.
- Advanced Formulation: Utilizes Polycaprolactone (PCL), a biocompatible material, ensuring safe and long-lasting results.
Usage Instructions:
Insert a needle into the injection syringe, and administer a precise amount of the product into the targeted skin area. Injection should be performed by a qualified medical professional to ensure accurate placement and optimal results.
Product Details:
- Origin: South Korea
- Category: Personal Care - Other Personal Care, Skin Care Set
- Keywords: Collagen, Wrinkle, Skin Regeneration, PCL
SOSUM PCL Solution is a highly effective treatment for those looking to rejuvenate their appearance by correcting soft tissue imperfections and stimulating natural collagen production. This product is an excellent choice for professionals seeking reliable and safe cosmetic solutions.
NEW BUYERS DISCOUNT!!!
First Time Users get 10% OFF on their first purchase + FREE Shipping!!! (use code : 10OFFTODAY), valid till 15.03.2025
QUANTITY DISCOUNT
EXTRA 12% OFF for orders over 1100 USD + FREE Shipping!!! (use code : QUANTITY5), valid till 15.03.2025
REWARDS & COUPONS
Purchase 11 Boxes & get 1 FREE Box (& FREE shipping), From 29 Boxes get 3 FREE Boxes (& FREE shipping. Use code : REWARDS93), valid till the 15.03.2025.